In this episode of Still Here: Contributing writer Simon Spichak discusses what experts say are Canada's "contradictory" and "concerning" latest guidelines for Long COVID, the CAN-PCC.

Plus, in research, we talk about a new study group to test the monoclonal antibody Pemgarda for Long COVID and post-vaccine syndrome, as well as a new study from Taiwan that found 14% of children developed Long COVID after being infected with SARS-CoV-2.

And we share updates on our summer fundraiser, too. The transcript for this episode can be found on our website, or jump to a specific part of the podcast below:

(00:00:00) Intro

(00:01:55) Top story: Behind the new "concerning", "contradictory" Canadian guidelines on Long COVID

(00:19:38) Research

(00:23:53) Updates on our summer fundraiser

(00:26:44) Outro

-

Mentioned in this episode (in order of appearance):

• The Sick Times: Experts call new Canadian Long COVID guidelines “contradictory” and “deeply concerning”
• Canadian Guidelines for Post-COVID-19 Condition (CAN-PCC)
• The Sick Times: Research updates, July 8
• The Sick Times: Frustrations, Denials, Long Drives: Immunocompromised People Can’t Access a Lifesaving COVID-19 Drug
• The Sick Times: Invivyd Chairman Marc Elia: The bureaucracy is killing people with Long COVID
• The Sick Times: Summer fundraiser: Help keep our essential work going into 2026

Additional audio in this episode: 

• Rude Mechanical Orchestra: Which Side Are You On? (orig. Florence Reece)